TB Research

<i>Mycobacterium tuberculosis</i> transcriptional regulator Rv1019 is upregulated in hypoxia and negatively regulates <i>Rv3230c</i> - <i>Rv3229c</i> operon encoding enzymes in the oleic acid biosynthetic pathway

Akhil Raj Pushparajan, Lekshmi K. Edison, Ramakrishnan Ajay Kumar

bioRxiv (Cold Spring Harbor Laboratory) · 2022-04

Abstract

Abstract The main obstacle in eradicating tuberculosis is the ability of Mycobacterium tuberculosis to remain dormant in the host, and then to get reactivated even years later under immuno-compromised conditions. Transcriptional regulation in intracellular pathogens plays an important role in adapting to the challenging environment inside the host cells. Previously, we demonstrated that Rv1019, a putative transcriptional regulator of M. tuberculosis H37Rv, is an autorepressor. We showed that, Rv1019 is cotranscribed with Rv1020 ( mfd ) and Rv1021 ( mazG ) encoding DNA repair proteins and negatively regulates the expression of these genes. In the present study, we show that Rv1019 also regulates the expression of the genes Rv3230c and Rv3229c ( desA3 ) which form a two-gene operon in M. tuberculosis . Constitutive expression of Rv1019 in M. tuberculosis significantly downregulated the expression of these genes. Employing Wayne’s hypoxia-induced dormancy model of M. tuberculosis , we show that Rv1019 is upregulated (3-fold) under hypoxia. Finally, by reporter assay, using M. smegmatis as a model, we validate that Rv1019 is recruited to the promoter of Rv3230c-Rv3229c during hypoxia and negatively regulates this operon which is involved in the biosynthesis of oleic acid.

MeSH terms

  • Operon
  • Biology
  • Gene
  • Mycobacterium smegmatis
  • Transcriptional regulation
  • Mycobacterium tuberculosis
  • Regulator
  • Downregulation and upregulation
  • Regulation of gene expression
  • Cell biology
  • Gene expression
  • Molecular biology